351 related articles for article (PubMed ID: 34712132)
1. Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis.
Zhou P; Zheng S; Wang E; Men P; Zhai S
Front Pharmacol; 2021; 12():696201. PubMed ID: 34712132
[No Abstract] [Full Text] [Related]
2. Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis.
Wang X; He X; Qi F; Liu J; Wu J
Front Pharmacol; 2022; 13():876386. PubMed ID: 35814207
[No Abstract] [Full Text] [Related]
3. Comparison of conbercept and ranibizumab for the treatment efficacy of diabetic macular edema: a Meta-analysis and systematic review.
Liu WS; Li YJ
Int J Ophthalmol; 2019; 12(9):1479-1486. PubMed ID: 31544046
[TBL] [Abstract][Full Text] [Related]
4. One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema.
Zhou Q; Guo C; You A; Wang D; Wang W; Zhang X
Mol Vis; 2019; 25():636-644. PubMed ID: 31700228
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Efficacy and Safety between Conbercept and Ranibizumab in Neovascular Age-Related Macular Degeneration: A Meta-Analysis of Randomized Controlled Trials.
Wang X; Yu C; Yang J; Liu Y; Xu Y; Li W
Ophthalmic Res; 2022; 65(2):140-151. PubMed ID: 34583363
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis.
Wang L; Zhang C; Hua R
Drug Des Devel Ther; 2018; 12():3625-3633. PubMed ID: 30464394
[TBL] [Abstract][Full Text] [Related]
7. Comparative quantitative analysis of optical coherence tomography angiography in varied morphologies of macular neovascularization following intravitreal conbercept and ranibizumab treatments for neovascular age‑related macular degeneration.
Li J; Yang Z; Li X; Li D; Yang J; Dang M
Exp Ther Med; 2024 May; 27(5):214. PubMed ID: 38590577
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model.
Cui Z; Zhou W; Chang Q; Zhang T; Wang H; Meng X; Liu Y; Yan H
Front Med (Lausanne); 2021; 8():750132. PubMed ID: 34926500
[No Abstract] [Full Text] [Related]
9. Efficiency and safety of laser photocoagulation with or without intravitreal ranibizumab for treatment of diabetic macular edema: a systematic review and Meta-analysis.
Qian TW; Zhao MY; Li XX; Xu X
Int J Ophthalmol; 2017; 10(7):1134-1143. PubMed ID: 28730118
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
Xu Y; Rong A; Xu W; Niu Y; Wang Z
BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and safety of anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: systematic review and Bayesian network meta-analysis.
Ye L; Jiaqi Z; Jianchao W; Zhaohui F; Liang Y; Xiaohui Z
Ther Adv Chronic Dis; 2020; 11():2040622320953349. PubMed ID: 32953000
[TBL] [Abstract][Full Text] [Related]
12. Conbercept for patients with age-related macular degeneration: a systematic review.
Zhang J; Liang Y; Xie J; Li D; Hu Q; Li X; Zheng W; He R
BMC Ophthalmol; 2018 Jun; 18(1):142. PubMed ID: 29902977
[TBL] [Abstract][Full Text] [Related]
13. Anti-vascular endothelial growth factor therapy for age-related macular degeneration: a systematic review and network meta-analysis.
Tricco AC; Thomas SM; Lillie E; Veroniki AA; Hamid JS; Pham B; Lee T; Agarwal A; Sharpe JP; Scott A; Warren R; Brahmbhatt R; Macdonald E; Janoudi G; Muni RH; Francisconi CLM; Richter T; Straus SE
Syst Rev; 2021 Dec; 10(1):315. PubMed ID: 34930439
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review and meta-analysis.
Yen WT; Wu CS; Yang CH; Chen YH; Lee CH; Hsu CR
Sci Rep; 2024 Jan; 14(1):2485. PubMed ID: 38291069
[TBL] [Abstract][Full Text] [Related]
15. Effects of Novel Anti-VEGF Agents with Intravitreal Conbercept in Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
Wang H; Zhou J; Sun C; Dong X
Evid Based Complement Alternat Med; 2021; 2021():9357108. PubMed ID: 33623533
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis.
Sun X; Zhang J; Tian J; Chen S; Zeng F; Yuan G
J Ophthalmol; 2020; 2020():5809081. PubMed ID: 32280526
[TBL] [Abstract][Full Text] [Related]
17. One-Year Effectiveness Study of Intravitreously Administered Conbercept
Wang H; Guo J; Tao S; Wang X; Liu X; Li T; Wang J; Yang X; Niu T; Liu D
Diabetes Ther; 2020 May; 11(5):1103-1117. PubMed ID: 32236812
[TBL] [Abstract][Full Text] [Related]
18. Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study.
Zhang W; Zhao G; Fan W; Zhao T
BMC Ophthalmol; 2021 Apr; 21(1):160. PubMed ID: 33789617
[TBL] [Abstract][Full Text] [Related]
19. Different approaches for treating myopic choroidal neovascularization: a network Meta-analysis.
Wu YJ; Feng YL; Yang JS; Fan H; Li WS
Int J Ophthalmol; 2023; 16(12):2105-2116. PubMed ID: 38111927
[TBL] [Abstract][Full Text] [Related]
20. Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies.
Carrasco J; Pietsch GA; Nicolas MP; Koerber C; Bennison C; Yoon J
Adv Ther; 2020 Jan; 37(1):300-315. PubMed ID: 31728825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
